| IMUX Stock | | | USD 1.10 0.01 0.90% |
Immunic financial indicator trend analysis is infinitely more than just investigating Immunic recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Immunic is a good investment. Please check the relationship between Immunic Cash Per Share and its Begin Period Cash Flow accounts. Check out
Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunic. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in employment.
For more information on how to buy Immunic Stock please use our
How to Invest in Immunic guide.
Cash Per Share vs Begin Period Cash Flow
Cash Per Share vs Begin Period Cash Flow Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Immunic Cash Per Share account and
Begin Period Cash Flow. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Immunic's Cash Per Share and Begin Period Cash Flow is -0.43. Overlapping area represents the amount of variation of Cash Per Share that can explain the historical movement of Begin Period Cash Flow in the same time period over historical financial statements of Immunic, assuming nothing else is changed. The correlation between historical values of Immunic's Cash Per Share and Begin Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash Per Share of Immunic are associated (or correlated) with its Begin Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Begin Period Cash Flow has no effect on the direction of Cash Per Share i.e., Immunic's Cash Per Share and Begin Period Cash Flow go up and down completely randomly.
Correlation Coefficient | -0.43 |
| Relationship Direction | Negative |
| Relationship Strength | Very Weak |
Cash Per Share
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.
Most indicators from Immunic's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Immunic current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immunic. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in employment.
For more information on how to buy Immunic Stock please use our
How to Invest in Immunic guide.
Selling General Administrative is likely to drop to about 14
M in 2024.
Issuance Of Capital Stock is likely to drop to about 810.4
K in 2024
Immunic fundamental ratios Correlations
Click cells to compare fundamentals
Immunic Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Immunic fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Additional Tools for Immunic Stock Analysis
When running Immunic's price analysis, check to
measure Immunic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunic is operating at the current time. Most of Immunic's value examination focuses on studying past and present price action to
predict the probability of Immunic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunic's price. Additionally, you may evaluate how the addition of Immunic to your portfolios can decrease your overall portfolio volatility.